chemotherapy-induced peripheral neuropathy

Ananda Pharma Confirms Safety of MRX1 CBD Drug, as Clinical Pain Trials Approach

Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.

Ben Stevens17 June 2026